Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Is This GlaxoSmithKline's Next Big Blockbuster?
Motley Fool
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Don't Blame AbbVie for Humira's Success
Motley Fool
AbbVie's Humira Success, Strong Pipeline Make It A Buy
Seeking Alpha
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Merck's Weakest Blockbuster?
Motley Fool